Chronic Pancreatitis‑Associated Biliary Stricture and IgG4‑Related Sclerosing Cholangitis: Evidence‑Based Guidance

Diagnostic Imaging Findings

Absence of peripancreatic inflammatory changes or fluid collections on MRCP indicates no concurrent acute pancreatitis, supporting a chronic disease state【1】.
Mildly elevated serum lipase without imaging evidence of inflammation suggests chronic pancreatic dysfunction rather than an acute episode, reinforcing the chronic pancreatitis diagnosis【1】.
MRCP image quality can be compromised by motion artifact, potentially reducing diagnostic accuracy, and should be interpreted with caution in this context【1】.

The presence of a common bile duct (CBD) stent reflects prior therapeutic endoscopic intervention for a biliary stricture, confirming that drainage has been attempted【2】.
Pneumobilia observed after stent placement is an expected finding, representing communication between the biliary tree and the gastrointestinal lumen【2】.

IgG4‑RSC may present with a focal stricture at the common hepatic duct (Type 4 pattern) or intra‑hepatic strictures (Type 2a pattern), a key imaging clue for this entity【3】.
Serum IgG4 is elevated in 50‑80 % of patients with IgG4‑related disease, but also in 9‑15 % of primary sclerosing cholangitis (PSC) patients, limiting its specificity【3】.
An IgG4/IgG1 ratio > 0.24 or serum IgG4 > 4 × the upper limit of normal improves specificity for IgG4‑related disease, aiding differentiation from PSC【3】.
Histologic confirmation requires >10 IgG4‑positive plasma cells per high‑power field and an IgG4⁺/IgG⁺ ratio > 40 %, providing definitive diagnostic evidence【3】.
If serum IgG4 exceeds 4 × ULN, IgG4‑related disease should be strongly considered; if the IgG4/IgG1 ratio exceeds 0.24, tissue sampling is recommended【3】.
Endoscopic papillary biopsies detect IgG4‑positive plasma cell infiltration in 53‑80 % of IgG4‑related pancreatitis cases, supporting their use when serology is equivocal【3】.
Normal serum IgG4 does not exclude IgG4‑related disease, as 20‑50 % of affected patients have normal levels, underscoring the need for tissue confirmation when suspicion remains【3】.

Cholangioscopic or fluoroscopically guided endobiliary biopsies provide higher diagnostic yield than brush cytology for biliary strictures, making them preferred when malignancy must be excluded【3】.

Repeat MRCP every 6–12 months to monitor for new masses, progressive stricturing, or a “beaded” appearance suggestive of PSC, ensuring early detection of malignant transformation【4】.
Serial imaging of the 1.1 cm left adrenal nodule at 6–12 month intervals is advised; stability supports a benign adenoma, whereas growth or new concerning features warrants further evaluation【4】.

All facts are derived from peer‑reviewed sources indicated by citation IDs. No patient‑identifiable information is included.

The American College of Radiology suggests that multifocal intrahepatic and extrahepatic bile duct strictures with a "beaded" appearance are indicative of primary sclerosing cholangitis (PSC) 5
Proximal intrahepatic bile duct strictures may indicate ischemic cholangitis, according to the Journal of Hepatology 5
Localized strictures, especially with associated mass or enhancement, raise concern for cholangiocarcinoma, as reported in Gut 6
Intrahepatic ductal dilatation without extrahepatic dilatation is highly suspicious for hilar obstruction, often from cholangiocarcinoma, according to Gut 6
Dilatation of both intra- and extrahepatic ducts suggests distal common bile duct obstruction, which may be due to pancreatic cancer, ampullary carcinoma, or choledocholithiasis, as stated in the Journal of the American College of Radiology 7, 8

Pancreatic duct dilatation (>3mm in head, >2mm in body/tail) suggests downstream obstruction, often from pancreatic adenocarcinoma, according to the Journal of the American College of Radiology 7, 6
Irregular narrowing of the pancreatic duct with side branch dilatation suggests chronic pancreatitis, as reported in the Journal of Hepatology 9
Abrupt cutoff of the pancreatic duct with upstream dilatation is highly concerning for pancreatic malignancy, according to the Journal of the American College of Radiology 7, 8

Evidence of vascular encasement or invasion on contrast-enhanced sequences accompanying MRCP suggests advanced malignancy, as stated in the Journal of the American College of Radiology 7, 6
Tumor-induced compression or thrombosis of the portal vein or hepatic artery indicates locally advanced disease that may be unresectable, according to Gut 6

MRCP has diminishing sensitivity for stones smaller than 4mm in size, as reported in the Journal of the American College of Radiology 8, 10
Abnormal enhancement around bile ducts may indicate cholangitis, which can complicate an obstructing bile duct stone, according to the Journal of the American College of Radiology 8
Asymmetric or nodular enhancement of the bile duct wall is concerning for cholangiocarcinoma, as stated in Gut 6